Condition: Irritable Bowel Syndrome · Diarrhea · Sponsor: Eli Lilly and Company
The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated, what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Diarrhea (IBS-D). The study drug will be administered subcutaneously (SC) (under the skin) when compared with placebo. The study will last approximately 35 weeks.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Del Sol Research Management - Mesa | Mesa, Arizona, United States | Recruiting |
| Smart Cures Clinical Research | Anaheim, California, United States | Recruiting |
| Om Research LLC | Lancaster, California, United States | Recruiting |
| United Medical Doctors - Los Alamitos | Los Alamitos, California, United States | Recruiting |
| Encore Medical Research | Hollywood, Florida, United States | Recruiting |
| Clinical Research of Osceola | Kissimmee, Florida, United States | Recruiting |
| Springfield Clinic - First | Springfield, Illinois, United States | Recruiting |
| Gastroenterology Health Partners | New Albany, Indiana, United States | Recruiting |
| Gastroenterology Health Partners | Louisville, Kentucky, United States | Recruiting |
| Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center | Wyoming, Michigan, United States | Recruiting |
| Mayo Clinic in Rochester, Minnesota | Rochester, Minnesota, United States | Not Yet Recruiting |
| Ohio Gastroenterology | Columbus, Ohio, United States | Recruiting |
+ 77 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07545759